Showing results (11-20 of 252) with videos related to
Sort By:
Pageof 26
Pharmacological Research|January 22, 2005
Hospital-based intensive monitoring of antibiotic-induced adverse events in a university hospitalFilomena Mazzeo, Annalisa Capuano, Amalia Avolio, et al.The Journal of Clinical Endocrinology and Metabolism|June 19, 2013
Fracture risk and bone mineral density in metabolic syndrome: a meta-analysisKatherine Esposito, Paolo Chiodini, Annalisa Capuano, et al.Endocrine|March 26, 2013
Should we abandon statins in the prevention of bone fractures?Katherine Esposito, Annalisa Capuano, Liberata Sportiello, et al.Vaccine|March 17, 2011
Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccinationElisabetta Parretta, Benedetta Ianniello, Fernanda Ferrazin, et al.Expert Opinion on Biological Therapy|March 29, 2014
The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?Maria Ida Maiorino, Michela Petrizzo, Annalisa Capuano, et al.British Journal of Pharmacology|July 22, 2004
Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical productionAntonella De Angelis, Barbara Rinaldi, Annalisa Capuano, et al.International Immunopharmacology|April 21, 2020
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatmentGabriella di Mauro, Cristina Scavone, Concetta Rafaniello, et al.Pharmacological Research|August 21, 2021
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studiesAnnamaria Mascolo, Cristina Scavone, Lucia Scisciola, et al.International Journal of Cardiology|October 14, 2015
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapyLiberata Sportiello, Concetta Rafaniello, Cristina Scavone, et al.Expert Opinion on Drug Safety|August 30, 2014
Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012Carmen Ferrajolo, Annalisa Capuano, Gianluca Trifirò, et al.Pageof 26